SIRT6 and cancer: In other cancer types, such as lung cancer (Desantis et al., 2018), prostate cancer (Bai et al., 2016), melanoma, and non-melanoma skin cancer (Garcia-Peterson et al., 2017), SIRT6 is upregulated both at mRNA and protein level, and acts as an oncogene responsible for cancer cell proliferation.